Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP–Consortium)

The Office of the Assistant Secretary for Preparedness and Response, through the Biomedical Advanced Research and Development Authority (BARDA), issued solicitation 75A50123D00003 to identify a Consortium Management Firm (CMF) for the Biopharmaceutical Manufacturing Preparedness-Consortium (BioMaP–Consortium). The CMF is responsible for establishing the consortium and conducting day-to-day management under the guidance of the BioMaP Branch of BARDA. Core responsibilities include managing technical, programmatic, financial, and administrative matters, as well as soliciting, awarding, and overseeing project agreements and sub-agreements for consortium members.

This procurement is classified under NAICS code 325414 for Biological Product (except Diagnostic) Manufacturing and PSC code AN42 for HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH. The administrative record for this solicitation includes three attachments: the primary solicitation document, a Statement of Objectives, and an amendment issued on August 9, 2023, containing responses to vendor questions. Shane Sarchiapone is the designated point of contact for this requirement.

The final deadline for responses is August 22, 2023, at 3:00 PM Eastern. This follows a schedule where questions were due by August 7, 2023, and notices of intent were required by August 10, 2023. All submissions and notices regarding the BioMaP-Consortium are to be delivered via email.